Kidney Cancer Coalition & KCAN: Stronger Together

Kidney Cancer Coalition and KCAN have joined forces to accelerate life-saving research and clinical trials for kidney cancer.

The union of these two complementary charitable organizations represents a promising step for the kidney cancer community.

Battling what is among the most prevalent forms of cancer among men (#6) and women (#10) in the U.S.*—yet still among the most under-funded and under-recognized cancers— patients, caregivers, advocates, and scientists are in dire need of greater awareness, funding, and action. That is our focus.

Together, we’ll be known as the Kidney Cancer Coalition—carrying that name forward while embracing the “CAN” legacy to reinforce our driven and optimistic vision for our role in the fight against this deadly disease.

As one, we bring proven effectiveness at raising money for research—from grassroots efforts, to private contributions and corporate grants, up through substantial federal funding. Our impact in just four combined years of existence includes:

Spearheading efforts to initiate a $45 million Congressional grant program for research;

Raising over $1 million through local efforts and events including our “Rock the Cure” fundraisers, with over $625,000 already put to work in research labs and studies;

Leading the first-ever grassroots-funded clinical trial for kidney cancer; and

Earning a reputation for being extremely efficient at deploying capital directly to clinical and scientific endeavors in pursuit of breakthroughs.

Our founders—Brenda and Ralph Knapp, who started Kidney Cancer Coalition in 2016, and Bryan Lewis, who formed KCAN in 2017—met at a symposium and quickly recognized the potential benefits of pooling their strengths and resources. These three devoted leaders have personal experiences with kidney cancer, as patients, caregivers, and advocates. Their commitment to the cause is profound.

Brenda, Ralph, and Bryan remain confident that we “CAN” find a cure in our lifetime, despite the historical lack of funding—particularly compared to other forms of cancer—which continues to leave a severe shortage of trials resulting in roughly 15,000 deaths in the U.S. each year.*

We believe it requires urgency, tenacity, and transparency to inspire giving, and to make the most of every dollar collected and we’re now better positioned to fulfill our collective mission as one unified team, working alongside our many partners to defeat this disease.

COMING SOON

KIDNEY CANCER RESEARCH SUMMIT

#KCRS2019

SEPTEMBER 2019

PHILADELPHIA, PA

Bryan Lewis, President & Co-Founder

Co-Chairs Drs. Hans Hammers & Tony Choueiri

Brenda Knapp, Treasurer & Co-Founder

We are proud to host the 1st annual Kidney Cancer Research Summit bringing together renowned scientists, young investigators, industry and research advocates.

ADVOCACY DAY 2019

We had a successful advocacy day on the Hill March 12th

Thank you to all who let your voice be heard

Interested in attending the next Capitol Hill advocacy day? Click HERE

Donate Now!

Since our inception in 2016, we have proudly given over $625,000 to Kidney Cancer Research!

WE ARE A GRASSROOTS ORGANIZATION DEDICATED TO MAKING A DIFFERENCE IN THE KIDNEY CANCER COMMUNITY

Funded major projects to date include:

  • RADVAX investigator led immunotherapy trial for 25 advanced kidney cancer patients at UT Southwestern combining Nivolumab, Ipilimumab and SBRT – currently recruiting

  • Support of UT Southwestern’s Kidney Cancer Research Program. 1 of only 2 SPOREs (Specialized Programs of Research Excellence) for Kidney Cancer in the US.

 Our primary sources of support are donations from the general public and fundraising.  

40 PEOPLE PER DAY DIE FROM KIDNEY CANCER

Our mission is to abolish Kidney Cancer as a threat to the life and health of patients through advocacy and accelerating research by  offering direct financial support for clinical and laboratory researchers with promising ideas.

LEARN MORE

Kidney Cancer strikes 63,340/year

14,970/year die from the disease

We want to help change those statistics!

News

August 8, 2018 / Front News, News Page

Columnist Robert Wilonsky Speaks About His Battle With Cancer

NBC Today Anchor Marc Fein: I had the honor of talking to DMN Dallas City Columnist Robert Wilonsky today about his battle with cancer. He was told he wouldn’t see his son’s next birthday. He did, and his story is remarkable.
Read More
August 6, 2018 / Front News, News Page

Late-stage kidney cancer should have killed me. Thanks to these Dallas doctors, I have a chance

Robert Wilonsky, City Columnist Last summer, my doctor told me I would probably be dead before my son went to...
Read More
August 21, 2017 / Front News, News Page

Immunotherapy Trial – Patient Success Story

72-year-old Larry Carlson was diagnosed with stage IV CCRCC in November of 2014. He came to the UT Southwestern Kidney Cancer Program shortly after. Larry shares his journey through diagnosis, surgery, and immunotherapy.
Read More